The relevance of alternative RNA splicing to pharmacogenomics
- 1 August 2003
- journal article
- review article
- Published by Elsevier in Trends in Biotechnology
- Vol. 21 (8) , 346-353
- https://doi.org/10.1016/s0167-7799(03)00146-x
Abstract
No abstract availableKeywords
This publication has 85 references indexed in Scilit:
- Defects in Pre-mRNA Processing as Causes of and Predisposition to DiseasesDNA and Cell Biology, 2002
- Flip and flop splice variants of AMPA receptor subunits in the spinal cord of amyotrophic lateral sclerosisSynapse, 2002
- Listening to silence and understanding nonsense: exonic mutations that affect splicingNature Reviews Genetics, 2002
- Gene expression profiling predicts clinical outcome of breast cancerNature, 2002
- Regulatory Functions of 3′UTRsBiochemical and Biophysical Research Communications, 2001
- Initial sequencing and analysis of the human genomeNature, 2001
- Cloning and Initial Analysis of the Human Multidrug Resistance-Related MVP/LRP Gene PromoterBiochemical and Biophysical Research Communications, 2000
- Ligand Binding Properties of Binary Complexes of Heparin and Immunoglobulin-like Modules of FGF Receptor 2Biochemical and Biophysical Research Communications, 2000
- Alternative Splicing of the mRNA Coding for the Human Endothelial Angiotensin-Converting Enzyme: A New Mechanism for SolubilizationBiochemical and Biophysical Research Communications, 1998
- P450 superfamily: update on new sequences, gene mapping, accession numbers and nomenclaturePharmacogenetics, 1996